Edwards Lifesciences Corporation which can be found using ticker (EW) now have 22 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between 105 and 73 with the average target price sitting at $93.82. Given that the stocks previous close was at $88.78 and the analysts are correct then we can expect a percentage increase in value of 5.7%. The 50 day MA is $83.48 and the 200 day MA is $82.98. The company has a market cap of 54.06B. The current share price for the company is: 89.18 USD
The potential market cap would be $57,131,622,711 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 36.85, revenue per share of 8.94 and a 13.05% return on assets.
